Previous close | 0.4000 |
Open | 0.4000 |
Bid | 0.3000 |
Ask | 1.0000 |
Strike | 5.00 |
Expiry date | 2024-06-21 |
Day's range | 0.4000 - 0.4000 |
Contract range | N/A |
Volume | |
Open interest | N/A |
EMERYVILLE, Calif., June 03, 2024--OmniAb, Inc. (NASDAQ: OABI) today announced the publication of a peer-reviewed paper titled "Chickens with a Truncated Light Chain Transgene Express Single-Domain H Chain-Only Antibodies" in the Journal of Immunology demonstrating that chickens can be genetically engineered to produce functional heavy chain-only single-domain antibodies.
Key Insights Using the 2 Stage Free Cash Flow to Equity, OmniAb fair value estimate is US$6.77 Current share price of...
EMERYVILLE, Calif., May 20, 2024--OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating at the Jefferies Global Healthcare Conference, being held June 4-6, 2024 at the Marriott Marquis in New York City. Management will be presenting a corporate overview on Wednesday, June 5th at 8:00 a.m. Eastern time and will be holding one-on-one meetings with investors.